Placebo to match LY3819469 clinical trials

J3L-MC-EZEB: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults with Elevated Lipoprotein(a)

This study is looking into a new medication called LY3819469 for adults with high levels of 'sticky' cholesterol, called Lipoprotein(a) or Lp(a). It aims to see if the medicine works to lower Lp(a) and if it's safe to use. Half the participants will get the medicine, and half will get a dummy pill.